---
title: "Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292447765.md"
description: "Berenberg Bank maintained its Buy rating on AstraZeneca with a £160 price target. The report highlights analyst Luisa Hector's strong track record in the healthcare sector. Concurrently, Citi issued a Buy rating for AstraZeneca, while Deutsche Bank maintained a Sell rating."
datetime: "2026-07-13T06:35:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292447765.md)
  - [en](https://longbridge.com/en/news/292447765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292447765.md)
---

# Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

In a report released today, Luisa Hector from Berenberg Bank maintained a Buy rating on AstraZeneca, with a price target of £160.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Hector covers the Healthcare sector, focusing on stocks such as Merck & Company, AstraZeneca, and AbbVie. According to TipRanks, Hector has an average return of 5.5% and a 60.45% success rate on recommended stocks.

In addition to Berenberg Bank, AstraZeneca also received a Buy from Citi’s Graham Parry in a report issued on July 10. However, on the same day, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [AstraZeneca’s Etcamah-CDK4/6 combo wins EU approval for 1st-line advanced ER-positive breast cancer](https://longbridge.com/en/news/293566585.md)
- [AstraZeneca asthma inhaler Trixeo wins positive EU CHMP opinion for approval](https://longbridge.com/en/news/293742333.md)
- [AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm](https://longbridge.com/en/news/293539668.md)
- [Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune | RPRX Stock News](https://longbridge.com/en/news/293463572.md)
- [BridgeBio: Buy Rating Reaffirmed on Strong Encaleret Data and Multi‑Asset Launch Outlook](https://longbridge.com/en/news/293508763.md)